CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −515 | 39,568 | ||
| 2024-04-01 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −2,000 | $72.96 | $146K | 96,304 |
| 2024-03-28 | Lofton Kevin E Director | Grant or award · Phantom Stock | +33.89 | 3,258.14 | ||
| 2024-03-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +2,555 | 14,603 | ||
| 2024-03-10 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −846 | $75.12 | $64K | 13,757 |
| 2024-03-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −2,555 | 29,268 | ||
| 2024-03-10 | Telman Deborah H EVP, Corporate Affairs & GC | Grant or award · Non-qualified Stock Option (Right to Buy) | +54,980 | 54,980 | ||
| 2024-03-10 | Telman Deborah H EVP, Corporate Affairs & GC | Grant or award · Restricted Stock Unit | +10,815 | 40,083 | ||
| 2024-03-10 | Patterson Sandra SVP, Controllership | Option exercise | +748 | 31,488 | ||
| 2024-03-10 | Patterson Sandra SVP, Controllership | Option exercise | +1,934 | 33,422 | ||
| 2024-03-10 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −790 | $75.12 | $59K | 32,632 |
| 2024-03-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −748 | 15,772 | ||
| 2024-03-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −1,934 | 13,838 | ||
| 2024-03-10 | Patterson Sandra SVP, Controllership | Grant or award · Non-qualified Stock Option (Right to Buy) | +13,660 | 13,660 | ||
| 2024-03-10 | Patterson Sandra SVP, Controllership | Grant or award · Restricted Stock Unit | +4,825 | 18,663 | ||
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Option exercise | +3,455 | 96,161 | ||
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Option exercise | +6,946 | 103,107 | ||
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −4,803 | $75.12 | $361K | 98,304 |
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −3,455 | 37,520 | ||
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −6,946 | 30,574 |
Page 28 of 30 · 590 trades